Solventum Corporation (SOLV) Return on Assets (ROA): 10.16%
Is Solventum Corporation’s return on assets (ROA) high or low?
Solventum Corporation's return on assets (ROA) of 10.16% is 38% above its 5-year average of 7.35%, near the high end of its 5-year range (0.00%–10.89%).
As of Friday, June 12, 2026. 43.10% above its 12-month average of 7.10%.
SOLV Return on Assets (ROA) Chart
SOLV Average Return on Assets (ROA) Chart
SOLV Current vs Average Return on Assets (ROA) Chart
SOLV Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
10.16%
RETURN ON ASSETS (ROA) AVG TTM
7.10%
RETURN ON ASSETS (ROA) AVG 3Y
8.43%
RETURN ON ASSETS (ROA) AVG 5Y
7.35%
RETURN ON ASSETS (ROA) AVG 10Y
7.35%
RETURN ON ASSETS (ROA) AVG 15Y
7.35%
RETURN ON ASSETS (ROA) AVG 20Y
7.35%
CURRENT VS TTM AVG
+43.10%
CURRENT VS 3Y AVG
+20.49%
CURRENT VS 5Y AVG
+38.23%
CURRENT VS 10Y AVG
+38.23%
CURRENT VS 15Y AVG
+38.23%
CURRENT VS 20Y AVG
+38.23%
SOLV Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 10.16% | 7.10% | 8.43% | 7.35% |
| Align Technology, Inc. (ALGN) | $12.64B | 6.81% | 6.68% | 6.69% | 12.75% |
| Baxter International Inc. (BAX) | $10.58B | -5.53% | -3.64% | -1.62% | 0.47% |
| Hologic, Inc. (HOLX) | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | -2.39% | -0.94% | 2.58% | 3.75% |
| Tempus AI, Inc. (TEM) | $8.65B | -14.19% | -43.49% | -42.71% | -41.26% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 1.72% | -6.26% | -11.14% | 1.46% |
| Moderna, Inc. (MRNA) | $19.70B | -27.80% | -24.02% | -10.32% | -0.33% |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | -0.58% | 11.88% | 0.12% | -6.73% |
| BioNTech SE (BNTX) | $22.39B | -6.03% | -3.96% | 9.16% | 17.06% |
Asset Efficiency
ROA
10.2%
ROE
28.8%
Solventum Corporation Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Solventum Corporation (SOLV)?
- The return on assets (ROA) for SOLV stock is 10.16%.
- Is Solventum Corporation's return on assets (ROA) high or low?
- Solventum Corporation's return on assets (ROA) of 10.16% is 38% above its 5-year average of 7.35%, near the high end of its 5-year range (0.00%–10.89%).
- What is the TTM average return on assets (ROA) for Solventum Corporation (SOLV)?
- The TTM average return on assets (ROA) for SOLV stock is 7.10%.
- What is the 3Y average return on assets (ROA) for Solventum Corporation (SOLV)?
- The 3Y average return on assets (ROA) for SOLV stock is 8.43%.
- What is the 5Y average return on assets (ROA) for Solventum Corporation (SOLV)?
- The 5Y average return on assets (ROA) for SOLV stock is 7.35%.
- What is the 10Y average return on assets (ROA) for Solventum Corporation (SOLV)?
- The 10Y average return on assets (ROA) for SOLV stock is 7.35%.
- What is the 15Y average return on assets (ROA) for Solventum Corporation (SOLV)?
- The 15Y average return on assets (ROA) for SOLV stock is 7.35%.
- What is the 20Y average return on assets (ROA) for Solventum Corporation (SOLV)?
- The 20Y average return on assets (ROA) for SOLV stock is 7.35%.
Solventum Corporation Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 10.89% |
| 2024-12-31 | 3.31% |
| 2023-12-31 | 9.65% |
| 2022-12-31 | 9.88% |
| 2021-12-31 | 10.37% |
| 2020-12-31 | 0.00% |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson